{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:50:22Z","timestamp":1778388622365,"version":"3.51.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.514313","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T04:46:25Z","timestamp":1603255585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Identification of Theaflavin-3,3\u2019-Digallate as a Novel Zika Virus Protease Inhibitor"],"prefix":"10.3389","volume":"11","author":[{"given":"Xiangling","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenchao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006411","article-title":"A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease","volume":"13","author":"Brecher","year":"2017","journal-title":"PloS Pathog."},{"key":"B2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antiviral Res."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765201920190105","article-title":"The role of natural products in modern drug discovery","author":"Calixto","year":"2019","journal-title":"Acad. Bras. Cienc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10136","DOI":"10.1073\/pnas.1805195115","article-title":"Targeting intramolecular proteinase NS2B\/3 cleavages for trans-dominant inhibition of dengue virus","volume":"115","author":"Constant","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.antiviral.2015.03.009","article-title":"Antiviral activity of theaflavin digallate against herpes simplex virus type 1","volume":"118","author":"de Oliveira","year":"2015","journal-title":"Antiviral Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3892\/ijo.2015.3257","article-title":"Theaflavin-3, 3\u2019-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways","volume":"48","author":"Gao","year":"2016","journal-title":"Int. J. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1099\/jgv.0.000381","article-title":"Zika virus: a previously slow pandemic spreads rapidly through the Americas","volume":"97","author":"Gatherer","year":"2016","journal-title":"J. Gen. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1002\/1873-3468.12443","article-title":"Substrate profiling of Zika virus NS2B-NS3 protease","volume":"590","author":"Gruba","year":"2016","journal-title":"FEBS Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(16)00320-2","article-title":"Zika virus and microcephaly: why is this situation a PHEIC","volume":"387","author":"Heymann","year":"2016","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/v9050097","article-title":"Historical Perspectives on Flavivirus Research","volume":"9","author":"Holbrook","year":"2017","journal-title":"Viruses"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2017.08.007","article-title":"Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice","volume":"146","author":"Kamiyama","year":"2017","journal-title":"Antiviral Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.tim.2017.07.001","article-title":"Zika Virus Protease: An Antiviral Drug Target","volume":"25","author":"Kang","year":"2017","journal-title":"Trends Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/v10020072","article-title":"Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models","volume":"10","author":"Kim","year":"2018","journal-title":"Viruses"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075144","article-title":"High-throughput screening (HTS) and hit validation to identify small molecule inhibitors with activity against NS3\/4A proteases from multiple hepatitis C virus genotypes","volume":"8","author":"Lee","year":"2013","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","article-title":"Identification of novel small molecule inhibitors against NS2B\/NS3 serine protease from Zika virus","volume":"139","author":"Lee","year":"2017","journal-title":"Antiviral Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/1873-3468.12741","article-title":"Structural characterization of the linked NS2B-NS3 protease of Zika virus","volume":"591","author":"Li","year":"2017","journal-title":"FEBS Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbrc.2018.06.062","article-title":"Characterization of molecular interactions between Zika virus protease and peptides derived from the C-terminus of NS2B","volume":"503","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10529-016-2261-6","article-title":"Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship","volume":"39","author":"Lim","year":"2017","journal-title":"Biotechnol. Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antiviral Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.antiviral.2017.03.011","article-title":"Solution conformations of a linked construct of the Zika virus NS2B-NS3 protease","volume":"142","author":"Mahawaththa","year":"2017","journal-title":"Antiviral Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.compbiolchem.2019.02.001","article-title":"Gp41 inhibitory activity prediction of theaflavin derivatives using ligand\/structure-based virtual screening approaches","volume":"79","author":"Mostashari-Rad","year":"2019","journal-title":"Comput. Biol. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-981-10-8727-1_13","article-title":"Strategies Towards Protease Inhibitors for Emerging Flaviviruses","volume":"1062","author":"Nitsche","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12551-019-00508-3","article-title":"Proteases from dengue, West Nile and Zika viruses as drug targets","volume":"11","author":"Nitsche","year":"2019","journal-title":"Biophys. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"13410","DOI":"10.1038\/ncomms13410","article-title":"Structure of the NS2B-NS3 protease from Zika virus after self-cleavage","volume":"7","author":"Phoo","year":"2016","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180632","article-title":"Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants","volume":"12","author":"Roy","year":"2017","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.antiviral.2016.12.018","article-title":"Extended substrate specificity and first potent irreversible inhibitor\/activity-based probe design for Zika virus NS2B-NS3 protease","volume":"139","author":"Rut","year":"2017","journal-title":"Antiviral Res."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tmaid.2015.10.004","article-title":"Entry routes for Zika virus in Brazil after 2014 world cup: New possibilities","volume":"14","author":"Salvador","year":"2016","journal-title":"Travel Med. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"15771","DOI":"10.1038\/s41598-017-15467-6","article-title":"Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis","volume":"7","author":"Shiryaev","year":"2017","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10787-018-0517-6","article-title":"25-hydroxycholesterol reduces inflammation, viral load and cell death in ZIKV-infected U-87 MG glial cell line","volume":"27","author":"Tricarico","year":"2019","journal-title":"Inflammopharmacology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"369ra179","DOI":"10.1126\/scitranslmed.aai8336","article-title":"Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus","volume":"8","author":"Wang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.fitote.2011.11.016","article-title":"A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection","volume":"83","author":"Yang","year":"2012","journal-title":"Fitoterapia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1126\/science.aai9309","article-title":"Crystal structure of unlinked NS2B-NS3 protease from Zika virus","volume":"354","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1084\/jem.20171093","article-title":"Zika virus has oncolytic activity against glioblastoma stem cells","volume":"214","author":"Zhu","year":"2017","journal-title":"J. Exp. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.stem.2019.11.016","article-title":"Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin alphavbeta5 Axis","volume":"26","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.coviro.2019.01.005","article-title":"Strategies for Zika drug discovery","volume":"35","author":"Zou","year":"2019","journal-title":"Curr. Opin. Virol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.514313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T04:46:26Z","timestamp":1603255586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.514313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":38,"alternative-id":["10.3389\/fphar.2020.514313"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.514313","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"article-number":"514313"}}